Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32,246Revenue $M580Net Margin (%)-127.3Z-Score11.5
Enterprise Value $M31,688EPS $-3.1Operating Margin %-119.4F-Score3
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-126.7Higher ROA y-yN
Price/Book29.810-y EBITDA Growth Rate %0Quick Ratio4.1Cash flow > EarningsY
Price/Sales54.05-y EBITDA Growth Rate %0Current Ratio4.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-32.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-61.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M242ROI % (ttm)-31.5Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXVanguard Health Care Fund 2014-12-31 Reduce-0.58%$101.1 - $120.78
($112.61)
$ 133.2015%Reduce -16.93%9,808,860
VRTXKen Fisher 2014-09-30 Reduce$84.74 - $113.9
($94.97)
$ 133.2029%Reduce -31.99%4,593
VRTXVanguard Health Care Fund 2014-06-30 Add0.04%$62.44 - $94.68
($70.13)
$ 133.2047%Add 1.54%11,807,500
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 133.2048%Sold Out0
VRTXKen Fisher 2014-06-30 Buy $62.44 - $93.77
($69.73)
$ 133.2048%New holding6,753
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 133.2041%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 133.2041%New holding10,000
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 133.2048%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 133.2040%Add 19.00%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 133.2045%Add 140.58%5,990,000
VRTXNWQ Managers 2013-06-30 Sold Out -0.09%$52.6 - $85.6
($73.64)
$ 133.2045%Sold Out0
VRTXVanguard Health Care Fund 2013-03-31 Add0.05%$43.65 - $54.97
($48.01)
$ 133.2064%Add 10.97%2,489,800
VRTXNWQ Managers 2013-03-31 Reduce-0.02%$41.9 - $54.97
($47.91)
$ 133.2064%Reduce -23.44%191,032
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 133.2060%Sold Out0
VRTXJoel Greenblatt 2012-09-30 Sold Out -0.08%$48.38 - $59.07
($53.5)
$ 133.2060%Sold Out0
VRTXNWQ Managers 2012-06-30 Reduce-0.27%$35.75 - $65.62
($50.92)
$ 133.2062%Reduce -83.86%188,842
VRTXVanguard Health Care Fund 2012-06-30 Reduce-0.08%$35.49 - $64.85
($51.21)
$ 133.2062%Reduce -15.13%2,243,700
VRTXJoel Greenblatt 2012-06-30 Buy 0.08%$35.75 - $65.62
($50.92)
$ 133.2062%New holding20,025
VRTXGeorge Soros 2012-06-30 Reduce-0.05%$35.75 - $65.62
($50.92)
$ 133.2062%Reduce -44.00%112,000
VRTXJean-Marie Eveillard 2012-06-30 Sold Out -0.02%$35.75 - $65.62
($50.92)
$ 133.2062%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOGER JOSHUA SDirector 2015-04-22Sell11,700$132.460.56view
BOGER JOSHUA SDirector 2015-04-15Sell11,700$129.253.06view
Silva Paul MSVP & Corp Controller 2015-04-13Sell1,125$128.63.58view
BOGER JOSHUA SDirector 2015-04-08Sell11,700$123.268.06view
MCGLYNN MARGARET GDirector 2015-04-06Sell12,500$118.3612.54view
Chodakewitz JeffreyEVP GMDA, CMO 2015-04-02Sell2,291$115.515.32view
BOGER JOSHUA SDirector 2015-04-01Sell11,700$115.8714.96view
BOGER JOSHUA SDirector 2015-03-25Sell11,700$120.7610.3view
Silva Paul MSVP & Corp Controller 2015-03-23Sell2,250$125.656.01view
Sachdev AmitEVP, Policy, Access & Value 2015-03-23Sell17,083$132.280.7view

Press Releases about VRTX :

    Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
    Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 
    Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
    Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
    WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 
    Idenix Pharmaceuticals Lagging Behind in Breakthrough Hepatitis C Drug Development Jul 13 2012 
    Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 
    Vertex Could Climb On New Drug, VX-222 Success Apr 21 2012 


    More From Other Websites
    Why Vertex Pharmaceuticals (VRTX) Stock Might be a Great Pick - Tale of the Tape Apr 23 2015
    Are M&A Replacing R&D In Pharma? Apr 22 2015
    Should Gilead Sciences Buy Vertex? Bernstein Says Yes, Maxim Says No Apr 21 2015
    Gilead's Stock Spikes on Possibility of Vertex Deal Apr 21 2015
    Gilead-Vertex Deal Has 'Low Probability' Of Happening, RBC Capital Says Apr 21 2015
    Time to take profits in biotech? Apr 21 2015
    Bernstein: It's Time For Gilead To Pull The Trigger On This Acquisition Apr 21 2015
    Gilead Should Buy Vertex Pharma for $45B Now, Analyst Says Apr 21 2015
    BioMed Realty, L.P. -- Moody's upgrades BioMed's senior unsecured ratings to Baa2; outlook is stable Apr 20 2015
    Biotech Investors Shouldn't Miss These Stocks This Earnings - Earnings ESP Apr 17 2015
    Will a New Vertex Drug for Cystic Fibrosis Become a Budget Buster? Apr 15 2015
    Growth In Drug Spend Is Hitting A 13-Year High. Note To Pharma: Innovation Pays. Apr 13 2015
    Stocks Up For Second Week As GE Soars Apr 10 2015
    Here are 10 local biotechs investing heavily in their future Apr 10 2015
    The BBJ’s top real estate stories of the week: April 10, 2015 Apr 10 2015
    Canaccord Ups Vertex To Buy On Cystic Fibrosis Drug Potential Apr 10 2015
    Vertex to Announce First Quarter 2015 Financial Results on April 29 Apr 09 2015
    Vertex to Announce First Quarter 2015 Financial Results on April 29 Apr 09 2015
    Stock Market News for April 08, 2015 - Market News Apr 08 2015
    Alnylam to move HQ to former Vertex site in big 2018 biotech shuffle Apr 06 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK